To the relief of patients diagnosed with hepatitis C, the U.S. Food and Drug Administration approved two new treatments late last year, and a few more are on the way.
Now scientists are solving another side of the disease’s problem: identifying the millions more who have the virus but don’t know it — and unwittingly pass it on. A report in the ACS journal Analytical Chemistry describes a novel, scrapbook-inspired test that does just that.
Xuan Mu, Zhi Zheng and colleagues point out that the hepatitis C virus (HCV), a blood-borne pathogen that can cause liver cirrhosis, cancer and even death, kills more people in the U.S. than HIV. It also infects an estimated 150 million people around the world. Although diagnostic tests exist, they require an initial screening and then a costly second test for confirmation. The extra office visits, money and time required for a definitive diagnosis means a lot of people simply can’t or won’t follow up. To make diagnosis more accessible, the researchers took advantage of the recent development of new, inexpensive paper-based medical technologies and applied it to HCV screening.
Taking a page from the popular scrapbooking pastime, the scientists used a flower-shaped metal paper cutter to punch out shapes from special paper for their diagnostic test. The method solves the problem of patterning the paper, made of nitrocellulose — a highly flammable substance — without using heat. They add antigens, antibodies and other chemicals to the paper to test patient samples. With one flower-shaped paper, they can conduct both HCV tests on a sample simultaneously in just minutes, instead of hours.
The Latest on: Paper-based diagnostics
[google_news title=”” keyword=”Paper-based diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Paper-based diagnostics
- Quest plans to purchase PathAI’s diagnostic lab as part of AI ramp-upon May 6, 2024 at 9:18 am
AI and digital technologies have tremendous potential to improve cancer care, and Quest has the know-how to scale and deliver innovations that are high quality, efficient and broadly accessible," said ...
- What is the association between post-diagnostic plant-based dietary patterns and the risk of prostate cancer progression?on May 6, 2024 at 6:13 am
The study aimed to investigate the impact of post-diagnosis consumption of plant-based food items on clinical outcomes in prostate cancer patients, focusing on two diet indices: an overall plant-based ...
- CORRECTING and REPLACING Babson Diagnostics Partners with Cynergy Wellness, Inc.on May 4, 2024 at 10:46 am
BABSON DIAGNOSTICS PARTNERS WITH CYNERGY WELLNESS, INC. Cynergy Wellness to provide clinician oversight of BetterWay™ customer-initiated blood testing orders. Babson Diagnostics ...
- New Google medical AI “Med-Gemini” is surprising doctorson May 4, 2024 at 5:03 am
Google has released a new medical AI aptly named Med-Gemini which builds on the companies powerful Gemini large language model ...
- Babson Diagnostics Partners with Cynergy Wellness, Inc.on May 3, 2024 at 5:37 am
Babson Diagnostics, a science-first health care technology company, today announced a partnership with Cynergy Wellness, Inc., a privately-owned provider of nationwide physician services for workplace ...
- Can At-Home Vision Tests Detect Active Neovascular AMD?on May 2, 2024 at 2:21 pm
Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported.
- Quest Diagnostics carves out PathAI's digital pathology lab, plots AI ramp-upon May 1, 2024 at 3:30 am
The testing giant will be buying out PathAI’s Memphis, Tennessee-based diagnostics laboratory, with plans to turn it into its own AI and digital R&D solutions center to help support its current ...
- Bioz, Inc.: Bioz and Copan Diagnostics Release AI-Based Citation Tools for Researcherson May 1, 2024 at 3:02 am
PALO ALTO, CA / ACCESSWIRE / May 1, 2024 / Bioz, Inc., a Bay Area-based AI company, and Copan Diagnostics, a specimen collection and laboratory automation leader, recently announced that Bioz will ...
- C Reactive Protein Testing Market Revenue Share By Company Till 2031on April 30, 2024 at 7:01 pm
Additionally, it is projected that developing point-of-care diagnostics that allow patients to do CRP testing would quicken the market's expansion. For instance, paper-based diagnostics that are ...
- Tuesday Sector Leaders: Diagnostics, Paper & Forest Productson April 30, 2024 at 9:21 am
In trading on Tuesday, diagnostics shares were relative leaders ... Also showing relative strength are paper & forest products shares, up on the day by about 0.8% as a group, led by Clearwater ...
via Bing News